Protara Therapeutics to Present at the H.C. Wainwright BioConnect Virtual Conference

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) will present at the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022. The presentation will be available on January 10 at 7:00 am ET through the Company's website. Protara focuses on developing therapies for cancer and rare diseases, featuring its lead program TARA-002 for non-muscle invasive bladder cancer and lymphatic malformations. Additionally, IV Choline Chloride targets intestinal failure-associated liver disease. The presentation will be archived for 90 days on their website.

NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the H.C. Wainwright BioConnect Virtual Conference being held from January 10-13, 2022.

The prerecorded presentation will become available on Monday, January 10, 2022 at 7:00am ET and can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived on the Company’s website for 90 days following the presentation.

About Protara Therapeutics, Inc.
Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:
Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

When is Protara Therapeutics' presentation at the H.C. Wainwright BioConnect Virtual Conference?

Protara Therapeutics will present at the H.C. Wainwright BioConnect Virtual Conference from January 10-13, 2022.

What time will Protara's presentation be available on January 10, 2022?

The prerecorded presentation will be available on January 10, 2022, at 7:00 am ET.

Where can I access Protara's presentation?

You can access Protara's presentation on their website in the Events and Presentations section.

What is the focus of Protara Therapeutics?

Protara Therapeutics focuses on developing therapies for cancer and rare diseases with significant unmet needs.

What are Protara's lead programs?

Protara's lead programs include TARA-002 for non-muscle invasive bladder cancer and IV Choline Chloride for intestinal failure-associated liver disease.